Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miles A Stewart

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Frontiers in Public Health|April 25, 2022
An Implementation Strategy to Develop Sustainable Surveillance Activities Through Adoption of a Target Operating ModelNatalie K Lee, Miles A Stewart, Jessica S Dymond, et al.
Frontiers in Public Health|February 14, 2022
Staffing and Capacity Planning for SARS-CoV-2 Monoclonal Antibody Infusion Facilities: A Performance Estimation Calculator Based on Discrete-Event SimulationsÇaglar Çaglayan, Jonathan Thornhill, Miles A Stewart, et al.
Open Forum Infectious Diseases|August 19, 2021
Real-world Effect of Monoclonal Antibody Treatment in COVID-19 Patients in a Diverse Population in the United StatesKaitlin Rainwater-Lovett, John T Redd, Miles A Stewart, et al.
Disaster Medicine and Public Health Preparedness|January 14, 2022
Implementation of SARS-CoV-2 Monoclonal Antibody Infusion Sites at Three Medical Centers in the United States: Strengths and Challenges Assessment to Inform COVID-19 Pandemic and Future Public Health Emergency UseAnastasia S Lambrou, John T Redd, Miles A Stewart, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Frontiers in Public Health|April 25, 2022
An Implementation Strategy to Develop Sustainable Surveillance Activities Through Adoption of a Target Operating ModelNatalie K Lee, Miles A Stewart, Jessica S Dymond, et al.
Frontiers in Public Health|February 14, 2022
Staffing and Capacity Planning for SARS-CoV-2 Monoclonal Antibody Infusion Facilities: A Performance Estimation Calculator Based on Discrete-Event SimulationsÇaglar Çaglayan, Jonathan Thornhill, Miles A Stewart, et al.
Open Forum Infectious Diseases|August 19, 2021
Real-world Effect of Monoclonal Antibody Treatment in COVID-19 Patients in a Diverse Population in the United StatesKaitlin Rainwater-Lovett, John T Redd, Miles A Stewart, et al.
Disaster Medicine and Public Health Preparedness|January 14, 2022
Implementation of SARS-CoV-2 Monoclonal Antibody Infusion Sites at Three Medical Centers in the United States: Strengths and Challenges Assessment to Inform COVID-19 Pandemic and Future Public Health Emergency UseAnastasia S Lambrou, John T Redd, Miles A Stewart, et al.
Pageof 1